To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Members: Correspondence
Wednesday 16th December 2020

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter from the hon. Member for Greenwich and Woolwich of 25 September 2020 on cancer diagnosis and treatment during the covid-19 outbreak, ref PO1259847.

Answered by Edward Argar - Minister of State (Ministry of Justice)

We are working to provide all Members and external correspondents with accurate answers to their correspondence, as well as supporting the Government’s response to the unprecedented challenge of the COVID-19 pandemic.

The hon. Member’s letter will be answered as soon as possible.


Written Question
Members: Correspondence
Friday 4th December 2020

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter from the hon. Member for Greenwich and Woolwich of 1 August 2020 regarding his constituent’s access to certain medication unavailable in the UK and the EU, ref PO1249786.

Answered by Edward Argar - Minister of State (Ministry of Justice)

The Department replied to the hon. Member’s letter on 9 November 2020.


Written Question
Members: Correspondence
Tuesday 24th November 2020

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when the Minister for Mental Health, Suicide Prevention and Patient Safety plans to respond to the letter from the hon. Member for Greenwich and Woolwich of 21 August 2020 on his constituent’s difficulties in travelling to the Royal Marsden hospital.

Answered by Edward Argar - Minister of State (Ministry of Justice)

The Department replied to the hon Member’s letter on 18 November 2020.


Written Question
Contact Tracing: Computer Software
Thursday 12th November 2020

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many individuals have received alerts from the NHS covid-19 app related specifically to a venue they have visited and checked into as required, since the app went live on 24 September 2020.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

The information is not held in the format requested.


Written Question
Gender Recognition: Clinics
Tuesday 10th March 2020

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate he has made of the current maximum waiting time from initial referral to a first appointment at each NHS gender identity clinic in England.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

The information is not available in the format requested.

As there is no specific pathway for gender reassignment, appointments cannot be identified.


Written Question
Gender Recognition: Clinics
Tuesday 10th March 2020

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate he has made of the average waiting time times for a full treatment pathway at each NHS gender identity clinic in England in each of the last three years.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

The information is not available in the format requested.

As there is no specific pathway for gender reassignment, appointments cannot be identified.


Written Question
Department of Health and Social Care: Living Wage
Tuesday 29th October 2019

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many staff his Department are paid less than the London Living Wage; and what requirements his Department places on contractors to pay the London Living Wage to London-based staff.

Answered by Caroline Dinenage

Whilst Government Departments do not seek accreditation to the Living Wage Foundation in relation to their rates of pay, the Department’s pay levels are above the current London Living Wage rates (as defined by the Living Wage Foundation) for directly employed members of staff and agency staff that are also sourced via the Crown Commercial Services Framework Contingent Labour Framework.

Contractor pay levels adhere to the statutory requirements to pay the National Minimum Wage or National Living Wage. We do not require pay levels for our contractors to be above London Living Wage levels.


Written Question
HIV Infection: Greater London
Tuesday 23rd July 2019

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate he has made of the level of demand for participation in the PrEP Impact trial in London.

Answered by Seema Kennedy

My Rt. hon. Friend the Secretary of State for Health and Social Care announced in January 2019 that places on the Pre-Exposure Prophylaxis (PrEP) Impact Trial would be doubled from 13,000 to 26,000. The planning of the Trial is led by Public Health England (PHE) and NHS England and is overseen by the PrEP Programme Oversight Board jointly chaired by PHE and NHS England, including allocation of places to reflect need.


Written Question
HIV Infection: Drugs
Tuesday 23rd July 2019

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if it is his Department’s policy that there should be continuous delivery of PrEP for participants after the conclusion of the PrEP Impact trial.

Answered by Seema Kennedy

Following my Rt. hon. Friend the Secretary of State for Health and Social Care’s announcement on 30 January that the Pre-Exposure Prophylaxis (PrEP) Impact Trial would be expanded to 26,000 people, NHS England has committed to fund the PrEP drug and research costs of these additional places, in line with current arrangements.

Local authority and clinic participation in the trial is on a voluntary basis. Participation costs of local authorities are met from existing resource allocations.

The 36 month PrEP Impact Trial is scheduled to continue until autumn 2020. Work is underway to prepare for a seamless transition from the PrEP trial to future commissioning arrangements, which includes consideration of funding options.


Written Question
Genito-urinary Medicine: Finance
Tuesday 23rd July 2019

Asked by: Matthew Pennycook (Labour - Greenwich and Woolwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what additional funding his Department will allocate to local authorities to fund additional sexual health appointments as a result of the expansion of the PrEP Impact trial.

Answered by Seema Kennedy

Following my Rt. hon. Friend the Secretary of State for Health and Social Care’s announcement on 30 January that the Pre-Exposure Prophylaxis (PrEP) Impact Trial would be expanded to 26,000 people, NHS England has committed to fund the PrEP drug and research costs of these additional places, in line with current arrangements.

Local authority and clinic participation in the trial is on a voluntary basis. Participation costs of local authorities are met from existing resource allocations.

The 36 month PrEP Impact Trial is scheduled to continue until autumn 2020. Work is underway to prepare for a seamless transition from the PrEP trial to future commissioning arrangements, which includes consideration of funding options.